Thelansis

  Transverse myelitis is a neurological disorder characterized by inflammation across both sides of one level or segment of the spinal cord, leading to damage or destruction of myelin, the fatty protective substance covering nerve cell fibres. This damage creates scars that disrupt communication between nerves in the spinal cord and the rest of the body. While most affected individuals will have only one attack, some may have multiple. Transverse myelitis can be the initial symptom of multiple sclerosis (MS) or neuromyelitis optica (NMO). The cause of transverse myelitis is not fully understood, but it is believed to result from an autoimmune reaction triggered by a viral or bacterial infection. In approximately 50% of cases, transverse myelitis is preceded by an infection. Various viral infections, including varicella zoster, herpes simplex, cytomegalovirus, Epstein-Barr, influenza, echovirus, HIV, hepatitis A, and rubella, and bacterial infections such as Mycoplasma pneumonia a...

 Acute transverse myelitis (TM) is a rare neuro-immune spinal cord disorder that can cause sudden weakness, sensory alterations, and bowel or bladder dysfunction. It usually occurs on its own as a complication of infection; however, it may also be part of a continuum of other neuro-inflammatory disorders. Acute disseminated encephalomyelitis, neuromyelitis optica spectrum disorder, multiple sclerosis, and acute flaccid myelitis are among the conditions covered. TM can occur anywhere along the spinal cord but most commonly affects the thoracic region. The disorder affects both sides of the spinal cord, resulting in bilateral deficiencies. The standard of care and the first-line therapy for treating transverse myelitis is intravenous glucocorticoids. The treatment aims to decrease inflammation and swelling while promoting and enhancing recovery. A differential diagnosis for Transverse myelitis includes any diseases causing myelopathy. The majority of patients with idiopathic transver...